Skip to content

Research on clinical characteristics of thyroid carcinoma lymph node metastasis

Research on clinical characteristics of thyroid carcinoma lymph node metastasis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043353
Enrollment
Unknown
Registered
2021-02-11
Start date
2016-01-01
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid carcinoma

Interventions

case series:Nil

Sponsors

Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Older than 18 years at the time of diagnosis; (2) Preoperative puncture pathology showed papillary thyroid carcinoma; (3) Undergo elective radical thyroid carcinoma; (4) Baseline clinical staging: CT1-4N0-2M0; (5) Patients and their family members can understand and are willing to participate in this clinical study, and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with puncture pathology inconsistent with postoperative pathology; (2) Patients who had undergone preoperative thyroid surgery or other neck surgery; (3) Patients with severe preoperative tumor involvement of nerve or trachea and corresponding symptoms; (4) Patients who had undergone preoperative ultrasound ablation of thyroid cancer; (5) Patients with distant tumor metastasis; (6) Patients who had participated in or were participating in other clinical trials within 4 weeks prior to inclusion; (7) Patients with ASA grade greater than III; (8) Physical status: patients with card score less than 60 points or ECOG score greater than 2 points; (9) Patients with liver dysfunction; (10) Patients with a history of severe mental illness; (11) pregnant or lactating women; (12) The researcher considered that the patient was not suitable to participate in the study because of other conditions.

Design outcomes

Primary

MeasureTime frame
lymph node metastasis;

Countries

China

Contacts

Public ContactQiu Weihua

Ruijin Hospital, Shanghai Jiaotong University School of Medicine

drqwh2003@126.com+86 18818270900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026